Duncan Gregory Scott 4
4 · Virios Therapeutics, Inc. · Filed Apr 6, 2021
Insider Transaction Report
Form 4
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2021-04-05$6.17/sh+15,675$96,757→ 19,579 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021.